Region Nordamerika
ISIN US89532E1091
Sektor Biotechnologie

At Trevena, our mission is to deliver innovative solutions to patients and healthcare providers confronting serious medical conditions. Our history is rooted in strong science – Trevena was founded to translate Nobel Prize-winning research into a new generation of groundbreaking medicines. Our novel approach to drug discovery has established us as pioneers in acute care medicine.


Titel Datum
Trevena-Aktie: Gibt der Aroon die Richtung vor?
Übergeordnet befindet sich die Aktie des Biotech-Unternehmens Trevena weiterhin im Abwärtstrend. ...
vor 4 Tagen
TREVENA INC - 10-Q, Quaterly Report vor 18 Tagen
BRIEF-Trevena Q1 Loss Per Share $0.14 vor 18 Tagen
TREVENA INC - 8-K, Current Report vor 18 Tagen
Trevena up 11% premarket on oliceridine deal in China vor 19 Tagen